[Federal Register Volume 71, Number 83 (Monday, May 1, 2006)]
[Notices]
[Page 25613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-6505]



[[Page 25613]]

=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 030-34437]


Notice of Availability of Environmental Assessment and Finding of 
No Significant Impact for License Amendment for DGI Biotechnologies, 
LLC's Facility in Edison, NJ

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of Availability.

-----------------------------------------------------------------------

FOR FURTHER INFORMATION CONTACT: Joseph Nick, Commercial and R&D 
Branch, Division of Nuclear Materials Safety, Region I, 475 Allendale 
Road, King of Prussia, Pennsylvania 19406, telephone (610) 337-5056, 
fax (610) 337-5269; or by e-mail: [email protected].

SUPPLEMENTARY INFORMATION:

I. Introduction

    The U.S. Nuclear Regulatory Commission (NRC) is considering the 
issuance of a license amendment to DGI Biotechnologies, LLC (DGI) for 
Materials License No. 29-30389-01, to authorize release of its facility 
in Edison, New Jersey for unrestricted use and terminate the license. 
NRC has prepared an Environmental Assessment (EA) in support of this 
proposed action in accordance with the requirements of 10 CFR part 51. 
Based on the EA, the NRC has concluded that a Finding of No Significant 
Impact (FONSI) is appropriate. The amendment will be issued following 
the publication of this Notice.

II. EA Summary

    The purpose of the proposed action is to authorize the release of 
the licensee's Edison, New Jersey facility for unrestricted use and 
terminate the license. DGI was authorized by NRC from 1997 to use 
radioactive materials for research and development purposes at the 
site. In 2003, DGI ceased operations with licensed materials at the 
Edison site and the DGI facility was taken over by Antyra, Inc. 
(Antyra). On September 28, 2005, Antyra requested that NRC release the 
facility for unrestricted use. Antyra has conducted surveys of the 
facility and provided information to the NRC to demonstrate that the 
site meets the license termination criteria in subpart E of 10 CFR part 
20 for unrestricted release.
    The NRC staff has prepared an EA in support of the license 
amendment. The facility was remediated and surveyed prior to the 
licensee requesting the license amendment. The NRC staff has reviewed 
the information and final status survey submitted by Antyra. Based on 
its review, the staff has determined that there are no additional 
remediation activities necessary to complete the proposed action. 
Therefore, the staff considered the impact of the residual 
radioactivity at the facility and concluded that since the residual 
radioactivity meets the requirements in subpart E of 10 CFR part 20, a 
Finding of No Significant Impact is appropriate.

III. Finding of No Significant Impact

    The staff has prepared the EA (summarized above) in support of the 
license amendment to terminate the license and release the facility for 
unrestricted use. The NRC staff has evaluated Antyra's request and the 
results of the surveys and has concluded that the completed action 
complies with the criteria in subpart E of 10 CFR part 20. The staff 
has found that the radiological environmental impacts from the action 
are bounded by the impacts evaluated by NUREG-1496, Volumes 1-3, 
``Generic Environmental Impact Statement in Support of Rulemaking on 
Radiological Criteria for License Termination of NRC-Licensed 
Facilities'' (ML042310492, ML042320379, and ML042330385). Additionally, 
no non-radiological or cumulative impacts were identified. On the basis 
of the EA, the NRC has concluded that there are no significant 
environmental impacts from the proposed action, and has determined not 
to prepare an environmental impact statement for the proposed action.

IV. Further Information

    Documents related to this action, including the application for the 
license amendment and supporting documentation, are available 
electronically at the NRC's Electronic Reading Room at http://www.nrc.gov/reading-rm/adams.html. From this site, you can access the 
NRC's Agencywide Document Access and Management System (ADAMS), which 
provides text and image files of NRC's public documents. The ADAMS 
accession numbers for the documents related to this Notice are: 
Environmental Assessment Related to Issuance of a License Amendment of 
U.S. Nuclear Regulatory Commission Materials License No. 29-30389-01, 
DGI Biotechnologies, LLC in Edison, New Jesey (ML061070474); and Final 
Status Survey Results for DGI Biotechnologies, LLC Facility, 40 
Talmadge Road, Edison, New Jersey (ML052840126). Persons who do not 
have access to ADAMS or who encounter problems in accessing the 
documents located in ADAMS, should contact the NRC PDR Reference staff 
by telephone at (800) 397-4209 or (301) 415-4737, or by e-mail to 
[email protected].
    Documents related to operations conducted under this license not 
specifically referenced in this Notice may not be electronically 
available and/or may not be publicly available. Persons who have an 
interest in reviewing these documents should submit a request to NRC 
under the Freedom of Information Act (FOIA). Instructions for 
submitting a FOIA request can be found on the NRC's Web site at http://www.nrc.gov/reading-rm/foia/foia-privacy.html.

    Dated at King of Prussia, Pennsylvania this 20th day of April, 
2006.

    For the Nuclear Regulatory Commission.
James P. Dwyer,
Chief, Commercial and R&D Branch, Division of Nuclear Materials Safety, 
Region I.
 [FR Doc. E6-6505 Filed 4-28-06; 8:45 am]
BILLING CODE 7590-01-P